seed
Stage
1
Investors
About
Herophilus develops novel neurodegenerative disease drugs by integrating human brain organoid models, high-throughput biology, and machine learning to improve the discovery of therapeutics with greater effectiveness.
Explore Herophilus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.